Molecular Imaging and Radio-Nuclide Therapy in Cancers

Dear Colleagues,

Radionuclide therapy is receiving increasing attention as an effective treatment in cancer, particularly for metastatic malignant tumor. Alpha emitters, which have higher linear energy transfer compared to beta emitters, have recently been used in clinical practice and show better treatment effect against cancers. Although supply of alpha emitters is still limited, it has a large potential for broad use as a systemic cancer therapy.

Diagnostic imaging plays an essential role in current clinical practice, especially cancer staging and detection of recurrence. Recently, new keyword “theranostics” have emerged as an integration of therapeutics and diagnostics. In theranostics, some compounds which target specific molecules are labeled by either diagnostic or therapeutic radionuclide so that imaging can be used as pre-treatment evaluation.

This Special Issue will highlight the current state-of-the-art in diagnostic imaging and radionuclide therapy and future prospects in cancer therapy.

Dr. Tadashi Watabe
Prof. Dr. Frederik Lars Giesel
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.